Bulletin 43: Inhaled Therapy in COPD is now available to all users of the PrescQIPP site. As some of you will be aware, since changing to a subscription based model, our bulletins and toolkits are only available to paid subscibers in the first instance for 4 months. This period has now passed for this bulletin and we are pleased to make you all aware that it can now be accessed by anyone via the site.
This bulletin considers the cost effective options for inhaled therapy for patients suffering with COPD, looking at the longer term costs of treatment. Along with audit reports, patient information materials, SystmOne searches and data collection tools, this bulletin offers a longer term view for CCGs, in line with the Medicines Optimisation agenda.
Inhaled Therapy in COPD